Millennium Management »

Outlook Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $206k 195k 1.06
2025-06-30 $542k 339k 1.60
2024-03-31 $331k 28k 11.94

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Outlook Therapeutics

Vanguard Group
Schonfeld Strategic Advisors
Morgan Stanley
BlackRock
Geode Capital Management
Susquehanna International
Millennium Management
Commonwealth Equity Services
Simplex Trading
State Street Corporation
Scotia Capital
LVW Advisors
UBS Group
Citadel Advisors
Goldman Sachs Group

View all funds holding Outlook Therapeutics